(Q35130335)

6 August 2017

title

Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? (English)

1 reference

6 August 2017

0 references

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24664520%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Stefano Bibbò

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24664520%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Giovanni Cammarota

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24664520%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Antonio Gasbarrini

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24664520%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

25 March 2014

1 reference

Internal and emergency medicine

6 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24664520%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24664520%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24664520%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

365-373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24664520%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11739-014-1069-4

11 June 2020

exact match

0 references

cites work

Host-bacterial mutualism in the human intestine

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

The human microbiome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Diversity, stability and resilience of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Linking long-term dietary patterns with gut microbial enterotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Diet rapidly and reproducibly alters the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Development of the human infant intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Unravelling the effects of the environment and host genotype on the gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Bacterial community variation in human body habitats across space and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Gut Microbiota in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

The gut microbiota in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Intestinal microbiota in functional bowel disorders: a Rome foundation report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

The intestinal microbiota and chronic disorders of the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

The role of gut microbiota in the pathogenesis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Gut microbiota and non-alcoholic fatty liver disease: new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Gut microbiota and hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Nutrition, the gut microbiome and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Diabetes, obesity and gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

RETRACTED: Gut microbiota and pediatric disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

The impact of gut microbes in allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Gut microbiota: Please pass the microbes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Microbial influences in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Low gut microbiota diversity in early infancy precedes asthma at school age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Therapeutic modulation of intestinal dysbiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Fix the antibiotics pipeline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Long-term impacts of antibiotic exposure on the human intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

An antibiotic-altered microbiota provides fuel for the enteric foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Shifting the balance: antibiotic effects on host-microbiota mutualism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Mechanisms of action of probiotics: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Examining the evidence for the use of probiotics in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

21 January 2018

Probiotics in transition

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Fiber and prebiotics: mechanisms and health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Bacteriotherapy using fecal flora: toying with human motions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Clostridium difficile--more difficult than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

The gut flora as a forgotten organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Durable alteration of the colonic microbiota by the administration of donor fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Fecal microbiota transplantation and emerging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Treating Clostridium difficile infection with fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Fecal microbiota transplantation for recurrent clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Success of self-administered home fecal transplantation for chronic Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Clostridium difficile spore germination: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Therapeutic potential of fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Fecal microbiota transplantation: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11739-014-1069-4

Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics

21 January 2018

1 reference

12 December 2020

Fecal microbiota transplantation: are we opening a can of worms?

1 reference

12 December 2020

Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa

1 reference

12 December 2020

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

12 December 2020

Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis

1 reference

12 December 2020

Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope

1 reference

12 December 2020

Prebiotics: the concept revisited

1 reference

12 December 2020

Probiotics and prebiotics: effects on diarrhea

1 reference

12 December 2020

Should we standardize the 1,700-year-old fecal microbiota transplantation?

1 reference

12 December 2020